Sleep Apnea
-
healthHealth Canada Approves Zepbound for Sleep Apnea in Obese Adults
The weight-loss drug becomes the first GLP-1 medication authorized in Canada to treat obstructive sleep apnea linked to obesity, offering a new option alongside CPAP therapy.
-
healthSleep Drooling: Medical Causes, Treatments, and Warning Signs
Experts explain why nocturnal drooling occurs, practical mitigation strategies, and when excessive salivation signals underlying neurological or airway disorders requiring medical intervention.
-
healthSleep Apnea Hypoxia May Blunt Emotion Recognition Speed
New study links oxygen drops from sleep apnea to slower emotion recognition, highlighting brain vulnerability beyond breathing.
-
healthGLP-1 Drug Weight Loss Linked to Lower Disease Risk
New study finds significant weight loss from GLP-1 drugs like Ozempic reduces risk of obesity-related conditions including sleep apnea and kidney disease.
-
health5 Surprising Triggers of High Blood Pressure
Discover unexpected factors like dehydration, sleep apnea, and loneliness that can spike blood pressure, a 'silent killer' affecting half of U.S. adults.
-
healthSleep Apnea Linked to Deceptive Muscle Changes, Study Reveals
Research shows sleep apnea patients may have more muscle mass, but it's often less dense and weaker, signaling broader metabolic issues.
-
healthSilent Sleep Apnea: The Hidden Health Risk You Can't Hear
Discover 'silent sleep apnea,' a dangerous condition that mimics regular sleep apnea symptoms but without snoring. Learn the risks, detection, and treatment options.
-
healthType D Personality Linked to Poor Sleep Apnea Therapy Adherence
New study reveals patients with Type D personality use CPAP devices less and report more side-effects, undermining treatment efficacy.